ARCHIVES

Niederhuber Says Resignation “Pro Forma,” Hopes To Stay As Director Or Lab Chief.

This article is from The Cancer Letter archive.

Vol. 34 No. 46 | December 19, 2008

Download PDF Visit The Full Archive

Related Articles

Translation Of “New Biology” Into Clinical Use Identified By DeVita As NCI’s Major Challenge

August 16, 1985

FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators

July 25, 2014

Wisconsin Funds State Cancer Control Program

July 15, 1988

Boston Meeting To Look At “IRBs At Crsswoad”

August 12, 1988

House Democrat Seeks Funds for NCI to Pursue 2015 Goal.

June 30, 2006

Erbitux Addition to Chemotherapy Regimen Can Make Inoperable Disease Operable

April 26, 2013